UNCY

Unicycive Therapeutics Inc. Common Stock (UNCY)

Stock · NASDAQ · Health Care

$5.26as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$6.85
Industry
Biotechnology: Pharmaceutical Preparations

Unicycive Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • UNCY
    Unicycive Therapeutics Inc. Common Stock
    $5.26
    ▼ 4.27%
    Market cap $138.47MP/E
  • MIST
    Milestone Pharmaceuticals Inc. Common Shares
    $1.17
    ▼ 2.10%
    Market cap $139.44MP/E
    $1$3.06
  • HURA
    TuHURA Biosciences Inc. Common Stock
    $2.11
    ▼ 1.17%
    Market cap $136.28MP/E
    $0.41$3.43
  • KZIA
    Kazia Therapeutics Limited American Depositary Shares
    $13.59
    ▼ 19.59%
    Market cap $141.81MP/E
    $4.86$17.4
  • GNLX
    Genelux Corporation Common Stock
    $2.66
    ▼ 7.64%
    Market cap $133.62MP/E
    $2.29$8.54
  • ADCT
    ADC Therapeutics SA Common Shares
    $1.15
    ▲ 2.68%
    Market cap $133.55MP/E
    $0.7796$4.98
  • VTVT
    vTv Therapeutics Inc. Class A Common Stock
    $32.17
    ▼ 1.92%
    Market cap $127.58MP/E 55.59
    $15.79$44

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
10.39M
Total value held
$67.93M
Institutional holders
49
Top holders this quarter
  • Unknown1.79M
  • Unknown1.40M
  • Unknown1.00M
  • Unknown939.2K
  • Unknown811.4K
  • Unknown796.6K
  • Unknown598.3K
  • Unknown473.6K
  • Unknown344.7K
  • Unknown225.0K

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.